Nikos Tserotas

RAFARM S.A.

RAFARM We evolve beyond the obvious; we make a positive impact on people's lives and ensure a healthier future. How far can we get? Well, we take a step forward, daily. Every day we discover new paths Every day we go beyond the obvious, we march ahead towards a healthier future. We are RAFARM, innovation-driven, dynamically growing, and one of the largest Greek pharmaceutical companies with an outward-looking orientation. We invest 10% of net turnover in Research and Development >100 RAFARM development products 10 new products are being developed every year by the R&D department 40 active pharmaceutical technology projects every year 1,100 active pharmaceutical licenses formulations We create new employment opportunities of high expertise We expand our exports worldwide (>60 countries) We have three state-of-the-art production units, new independent Research Center and storage space, with a total area of 16,000 sq.m. We are implementing one of the largest investment programs for years 2021-2025 in Greece, amounting to €65 million We rapidly grow our commercial activity in the domestic market and we are expanding our product portfolio. At RAFARM, we are driven by knowledge; that's why we are constantly developing thus enhancing our expertise in the development and production of ophthalmic and injectable pharmaceutical products. We achieve results that are beyond the obvious due to our team of highly knowledgeable R&D scientists, the cutting-edge technology we apply in production and our holistic approach to regulatory affairs. We act with promptness and agility. We adapt to the needs of the constantly developing pharmaceutical field making use of technology, our customer-oriented approach and primary focus on the individual. Why to partner with us? o Enriched options of complex pharmaceutical products o Flexible business partnerships worldwide o R&D extensive expertise on sterile forms o Focus on time to market o Supplier reliability